According to relevant data, Rongchang Bio plans to lay off 30% employees in 2022 in order to maintain business development and cut costs.
Rongchang Biopharmaceutical (Yantai) Co., Ltd. was established on July 4, 2008. The legal representative is Wang Weidong. The business scope of the company includes: research and development, production and sales of pharmaceutical products and diagnostic reagent products, technical services and technology transfer related to the above products and their research and development, and import and export of goods or technologies (except those prohibited by the state or involving administrative examination and approval).